RxDoctor Payments Data

Mandy Klass, MD

Family Medicine · Glandorf, OHNPI 1235135260

Payments from drug & device makers

$4,173in general payments, 2019–2025

Across 32 payments — averaging $130.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$4K
  • Novo Nordisk$66
  • Abbott$62
  • AbbVie$44
  • Lilly USA, LLC$39
  • Exact Sciences$23
  • plus $115 from 7 others

What the payments were for

  • Consulting fees$2,29655%
  • Travel & lodging$1,24030%
  • Food & beverage$63715%

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,173 in reported general payments places this provider in the 85th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$296,228
Medicare patients
484
Services billed
6,438

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban232$204,786
MounjaroTirzepatide128$169,683
TrulicityDulaglutide121$150,985
Repatha SureclickEvolocumab61$89,337
OzempicSemaglutide51$85,979
XareltoRivaroxaban75$75,493
JanuviaSitagliptin Phosphate68$64,328
JardianceEmpagliflozin52$52,458
FarxigaDapagliflozin Propanediol50$51,223
RybelsusSemaglutide32$49,611
Bydureon BciseExenatide Microspheres23$26,557
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog19$25,729
Tresiba Flextouch U-100Insulin Degludec31$24,885
MyrbetriqMirabegron43$21,043
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog88$19,980

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$39$320,668249 claims
PfizerEliquis, Paxlovid$14$211,580256 claims
Novo NordiskOzempic, Rybelsus$66$135,59083 claims
AstraZenecaFarxiga, Brilinta$19$64,35565 claims
GSKTrelegy Ellipta, Breo Ellipta$14$18,31734 claims
AbbVieRestasis$44$6,53614 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in Glandorf

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →